Tiakis Advances Tiprelestat into Phase II for Pulmonary Hypertension
Kiel, Germany, December 2, 2025 — Tiakis Biotech has announced that it has successfully completed the required preclinical data...
rare disease
Advertisement
Tinlarebant Phase 3 Trial Marks Major Breakthrough for STGD1
San Diego, December 1, 2025 — Belite Bio has announced positive topline results from the pivotal global Phase 3...
Regeneron and Tessera Unite to Develop TSRA-196 Therapy
Tarrytown, New York & Somerville, Massachusetts, December 1, 2025 — Regeneron and Tessera Therapeutics have announced a global collaboration...
Koselugo Secures US Approval, Advancing Targeted NF1 Care
Wilmington, Delaware, November 2025 AstraZeneca has announced that Koselugo (selumetinib) has received expanded FDA approval in the United States...
EMA Positive Opinion Grants Orphan Drug Hope for CTCL Treatment
Dateline – November 17 2025 | Lund, Sweden BioInvent International AB (“BioInvent”), a clinical-stage biotech company focused on novel...
Advertisements
Fortress Biotech Reports Strong Q3 Growth and Pipeline Progress
MIAMI, FL — November 14, 2025 — Fortress Biotech announced its third-quarter 2025 financial results, highlighting sustained revenue growth,...
Rhythm Pharmaceuticals Presents Four New Datasets at ObesityWeek® 2025
Boston, November 10, 2025 — Rhythm Pharmaceuticals, Inc. has announced the presentation of four pivotal datasets at ObesityWeek® 2025,...
Mirum Pharmaceuticals Presents New Data from LIVMARLI and Volixibat Programs at AASLD 2025
FOSTER CITY, Calif., November 7, 2025 — Mirum Pharmaceuticals, Inc., a biopharmaceutical company dedicated to transforming the lives of...
MavriX Bio Doses First Patient in Landmark ASCEND-AS Gene Therapy Trial
Middleton, Massachusetts – November 6, 2025 – MavriX Bio, a clinical-stage biotechnology company focused on transformative genetic medicines, announced...
Pasithea Activates UAB Clinical Site for PAS-004 NF1 Trial
MIAMI, November 4, 2025: Pasithea Therapeutics Corp. has announced the activation of a new clinical trial site at the...
Advertisement
